"However, I believe that they could double – or even treble in value – if the company commercialises either the Platypus or GPA project. The downside risk looks limited given cash backs up more than half Parkmead’s market capitalisation, and the profitable Dutch gas operations means that the company actually generates positive cash flow. Strong buy."
"Another company that has recently sprung up in the litigation finance sector is Litigation Capital Management (LSE: LIT). With a market capitalisation of only £100m at the time of writing, compared to Burford’s £3.6bn, the business is a tiddler compared to its larger peer.
However, if the firm can replicate Burford’s success, I think investors could double or even triple their money with this enterprise over the next few years."
"If earnings per share continue to grow at 100% to 200% per annum, it could be worth 180p to 260p in the near future."
"Importantly, the agreement boosts the number of potential funding opportunities available to Litigation Capital. The shares have reacted positively to the news flow, up by 20 per cent on my buy-in price of 77.5p, and are priced on 2.4 times pro-forma net asset value, a multiple that is set to drop sharply if, as I strongly suspect, Litigation Capital continues to produce eye-catching returns on its portfolio. Buy."